Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 18, Issue 12, Pages 1217-1225
Publisher
Wiley
Online
2016-07-23
DOI
10.1111/dom.12748
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metformin
- (2016) D. J. Nunez et al. DIABETES OBESITY & METABOLISM
- Metformin and the gastrointestinal tract
- (2016) Laura J. McCreight et al. DIABETOLOGIA
- GLP-1 based therapies: clinical implications for gastroenterologists
- (2016) Mark M Smits et al. GUT
- Incretin-based therapy and acute cholecystitis: a review of case reports and EudraVigilance spontaneous adverse drug reaction reporting database
- (2016) V. Pizzimenti et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes
- (2015) Mark M Smits et al. BMJ Open
- Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus
- (2015) Hideaki Jinnouchi et al. Journal of Diabetes Research
- Beyond intestinal soap—bile acids in metabolic control
- (2014) Folkert Kuipers et al. Nature Reviews Endocrinology
- Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus
- (2014) Antonella Napolitano et al. PLoS One
- Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults
- (2013) J van Can et al. INTERNATIONAL JOURNAL OF OBESITY
- Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity
- (2013) Anne Vrieze et al. JOURNAL OF HEPATOLOGY
- An acidic link
- (2013) Suzanne Devkota et al. NATURE
- Bile acid receptors as targets for drug development
- (2013) Frank G. Schaap et al. Nature Reviews Gastroenterology & Hepatology
- Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects
- (2012) Jutta Keller et al. REGULATORY PEPTIDES
- Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
- (2010) Richard E Pratley et al. LANCET
- Early Changes in Postprandial Gallbladder Emptying in Morbidly Obese Patients Undergoing Roux-en-Y Gastric Bypass: Correlation with the Occurrence of Biliary Sludge and Gallstones
- (2008) Michel Bastouly et al. OBESITY SURGERY
- Prebiotic oligosaccharides and the enterohepatic circulation of bile salts in rats
- (2007) Hester van Meer et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation